-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation